The Peabody Daily Log: 5/8/99
Have a PFun weekend!
BigKNY3
_______________________________________________
PFE Weekly Highlights:
-A pending Peabody Valley (113.38) was set on 5/5/99 (Target Valley was 113.39)
PFE Upcoming Events:
-5/21/99: Expected FDA approval of Vioxx, a Cox-II antiarthritic from Merck
-6/30/99: Effective date of PFE 3-1 split after market close
________________________________________________
Check out the PFE Chart and TA analysis
stockconsultant.com
PFE heads on up
- Click here for a 5 day comparison between PFE and the general markets
quicken.com
MRK makes a move ....with Vioxx approval less than two weeks away
-Click here for a 5 day comparison among PFE, MRK and the Dow.
quicken.com
WLA trails PFE over the last 5 years
Click here for a 5 year comparison among PFE, WLA and the Dow.
quicken.com
#1 AMGN is still of all Big Pharmas but facing a challenge from JNJ
Click here for a YTD comparison between Big Pharma leader AMGN and PFE.
quicken.com
Glaxo is still struggling in 1999
A comparison of PFE and Glaxo
quicken.com
PFE is smoking compared to Philip Morris (MO)
A three-year comparison between PFE and Phillip Morris.
quicken.com
The not so great ED battle over the last year
quicken.com
_________________________________________
The Peabody Log
Key: Peabody Peak (Intermediate High)
Peabody Valley (Intermediate Low)
___________________________________________________
PFE PFE PFE
Date Volume High/Ask Low/Bid Close Milestones
05/04/98 4,863,200 114 1/2 112 3/8 112 5/8 Viagra Rxs (207M)
05/05/98 5,882,900 112 3/4 109 3/4 111 11/16 AAO V vision
05/06/98 4,292,100 112 3/4 108 11/16 108 3/4
05/07/98 5,328,000 110 104 3/4 106 15/16
05/08/98 4,392,900 111 3/8 107 1/2 111 3/16 Bob Dole in V trials
05/11/98 5,262,500 113 3/4 110 111 Viagra Rxs (279M)
05/12/98 3,895,800 111 15/16 110 1/8 111 7/8
05/13/98 3,248,300 112 3/4 110 1/8 110 1/8
05/14/98 5,065,800 110 5/16 107 1/8 108
05/15/98 6,623,300 108 15/16 104 7/16 104 7/16 Peabody Valley
05/18/98 5,707,100 110 11/16 105 110 1/2 Viagra Rxs (300M)
05/19/98 7,552,000 113 11/16 111 9/16 112 13/16
05/20/98 3,474,200 114 3/16 112 1/8 112 13/16 Peabody Peak
05/21/98 6,291,800 112 13/16 108 1/16 109 1/8 Viagra/Nitro warning
05/22/98 9,702,600 109 7/8 104 105 7/16 V associated with 6 deaths
05/25/98 Memorial Day
05/26/98 6,303,800 106 15/16 103 1/16 103 3/16
05/27/98 6,692,200 108 101 3/8 108 ML maintains buy
05/28/98 4,064,500 107 5/8 105 5/8 106 3/8 PFE supports Viagra
05/29/98 3,741,100 107 15/16 104 1/2 104 13/16 ICOS in news
06/01/98 4,251,100 104 7/8 100 3/8 103 15/16 Peabody Valley
06/02/98 3,138,200 105 7/8 102 1/2 103 3/8 AUA Meeting
06/03/98 2,625,500 104 15/16 102 13/16 103 AUA Meeting
06/04/98 3,698,400 107 5/8 102 3/16 107 AUA Meeting
06/05/98 4,231,500 108 3/4 106 108 3/8
06/08/98 2,809,200 109 13/16 107 1/2 108 7/16
06/09/98 6,319,400 112 7/8 107 3/4 112 1/2 FDA V Release
06/10/98 4,856,200 111 1/8 107 1/16 109 WSJ Drug Interactions
06/11/98 3,273,300 110 3/8 107 107
06/12/98 3,399,500 109 1/2 106 5/8 109 3/8
06/15/98 3,134,700 109 1/4 106 7/8 108 3/8 Dow- 200
06/16/98 3,376,700 110 3/8 108 1/8 109 11/16 Schneider sold
06/17/98 4,463,200 112 11/16 110 1/2 112 1/16
06/18/98 4,147,600 114 15/16 112 3/16 114 1/4 Peabody Peak
06/19/98 5,484,900 114 15/16 109 13/16 111 1/4 Zeldox non-approval
06/22/98 3,177,200 112 3/4 109 13/16 111 7/16
06/23/98 3,961,200 111 15/16 109 1/4 110 3/16
06/24/98 3,736,800 110 3/8 108 3/4 110 1/8
06/25/98 2,878,000 112 1/2 110 1/2 110 13/16
06/26/98 2,635,800 112 5/8 110 5/8 111 15/16
06/29/98 5,244,400 111 1/2 108 1/4 109 15/16
06/30/98 5,190,200 108 3/4 106 5/8 108 1/2 DLJ Switch to WLA
07/01/98 3,857,700 109 15/16 106 5/16 107 3/16
07/02/98 2,740,300 109 1/2 106 9/16 107 1/2 Public Citizen/HMOs
07/03/98 Independence Day Barrons: V to Fade?
07/06/98 4,746,500 109 1/2 105 5/8 109 7/16 Peabody Valley
07/07/98 3,661,200 111 9/16 109 9/16 111 IMS: V to $1 Billion
07/08/98 3,920,100 114 3/16 111 1/8 113 1/2
07/09/98 4,338,600 115 5/8 112 3/4 115 5/8 EPS: $0.47 (+$.03)
07/10/98 8,446,800 118 1/8 113 118
07/13/98 5,540,600 120 5/8 117 15/16 118 11/16
07/14/98 4,130,500 120 9/16 118 1/16 118 9/16 Peabody Peak
07/15/98 3,541,400 118 9/16 115 13/16 116
07/16/98 3,199,300 117 7/8 115 3/16 117 13/16
07/17/98 3,128,700 117 1/4 115 5/8 115 5/8 Viagra lawsuit
07/20/98 2,964,100 118 1/2 115 9/16 117 15/16 V Rxs -13.8%
07/21/98 3,706,300 117 7/8 114 1/16 114 1/8 MRK misses EPS
07/22/98 4,538,100 116 3/4 111 3/8 116 3/8
07/23/98 4,107,100 115 1/2 111 111 5/8 Dow -196
07/24/98 4,877,700 114 3/4 112 113 1/2 Upbeat analysts' meeting
07/27/98 3,643,900 114 13/16 111 5/8 114 V Rxs +5.8%
07/28/98 3,365,500 114 111 111 5/8
07/29/98 3,704,700 112 3/4 109 1/8 109 1/8 Valley strike price reached
07/30/98 2,714,700 112 3/8 109 7/8 112 Dow +112
07/31/98 2,776,900 112 5/8 108 9/16 110 1/16
08/03/98 2,637,600 111 1/8 108 5/8 109 11/16 V Rxs -6.0%
08/04/98 5,248,300 110 3/4 104 3/4 105 Dow -299
08/05/98 4,556,900 106 3/8 102 5/8 105 15/16
08/06/98 3,355,000 106 7/8 104 1/16 105 5/16
08/07/98 4,363,300 105 1/2 102 1/8 103 1/2
08/10/98 3,287,500 105 3/4 103 1/2 103 13/16 ACC/AHA V Initial Report
08/11/98 5,898,100 104 5/16 98 1/2 103 15/16 Peabody Valley
08/12/98 3,858,800 104 15/16 101 1/4 101 15/16 WSJ:-2 V eye patients
08/13/98 3,614,500 104 101 1/2 102
08/14/98 2,680,800 103 1/4 101 1/16 101 3/16 Howmedica Sold
08/17/98 4,645,900 104 7/8 100 3/4 104 5/8 V Rxs +1%
08/18/98 4,349,900 107 9/16 103 7/16 107 1/2
08/19/98 3,343,200 108 15/16 106 3/8 108 15/16 Peabody Peak
08/20/98 3,194,400 108 13/16 105 1/2 105 3/4 Public Citizen V petition
08/21/98 3,887,200 106 1/4 102 1/16 105 7/8 Soros reports $.5B position
08/24/98 4,058,600 108 1/8 104 7/16 104 15/16 Celebrex expedited review
08/25/98 5,241,900 108 5/8 106 106 1/2 EU V Approval
08/26/98 4,242,900 108 7/8 103 5/8 108 1/8 V associated w 69 deaths
08/27/98 4,053,100 107 3/4 103 1/2 103 13/16 Dow -358
08/28/98 4,821,800 104 7/8 100 3/8 101 5/8 Dow-114
08/31/98 8,156,300 102 1/16 93 93 Dow-512
09/01/98 10,640,800 99 92 96 1/2 Peabody Valley
09/02/98 6,494,600 101 5/8 98 3/8 100 1/16
09/03/98 4,944,000 102 1/16 98 99 13/16 NEJM V Letters
09/04/98 9,096,100 96 1/4 93 1/2 95 1/8 Morgan Stanley Downgrade
09/07/98 Labor Day
09/08/98 5,358,100 100 13/16 97 1/16 100 3/4 DJ: +381
09/09/98 4,725,000 101 9/16 98 98 3/16 DJ:-156
09/10/98 4,324,600 97 93 9/16 94 1/2 DJ:-249/Clinton
09/11/98 6,451,300 100 13/16 95 100 1/2 ML supports Pharma
09/14/98 3,675,400 103 5/8 100 3/4 103 1/8 V Rxs +10%
09/15/98 2,603,500 103 7/8 101 1/2 102 9/16 EU V Approval
09/16/98 3,269,200 103 100 1/8 101 1/2 V not on NHS
09/17/98 2,648,100 100 1/16 98 1/4 99 1/4
09/18/98 3,523,400 99 7/8 97 1/4 97 1/4 Lancet V letter
09/21/98 2,869,900 99 1/8 95 97 5/8 Peabody Valley/Clinton Tapes
09/22/98 3,136,700 101 1/2 99 1/4 101 7/16
09/23/98 4,764,800 106 1/2 101 1/2 106 1/2 Dow +257
09/24/98 5,101,800 108 3/4 104 3/8 107 1/2 $5 B Stock Buyback
09/25/98 2,864,400 108 105 3/4 106 5/8
09/28/98 3,235,200 109 3/16 105 1/4 106 1/16 Peabody Peak
09/29/98 3,052,500 108 1/8 105 5/8 106 13/16 Fed reduces rates
09/30/98 3,627,600 108 1/16 105 5/8 105 15/16 DRIP day
10/01/98 3,853,400 104 11/16 99 3/8 99 5/8 Dow-210 LLY/ICOS
10/02/98 4,309,500 100 96 1/2 99 1/16
10/05/98 5,505,700 98 13/16 93 94 5/8 V Rxs -5%
10/06/98 7,462,200 96 11/16 88 1/8 89 3/8
10/07/98 6,766,000 92 15/16 88 3/4 90 5/8 JP Morgan recommends PFE
10/08/98 5,915,200 90 86 89 5/8 Peabody Valley
10/09/98 3,594,400 93 3/4 88 1/2 92 15/16 Dow +167
10/12/98 2,570,700 96 15/16 93 1/16 93 1/4 Peabody Peak
10/13/98 2,567,700 96 3/8 93 1/4 95 1/2 EPS $0.51 -$0.6 from Zachs
10/14/98 11,810,800 97 1/8 88 1/2 96 3/8 Analysts reiterate buys
10/15/98 4,761,600 99 1/4 94 9/16 97 1/2 Dow +330, Fed reduces rates
10/16/98 3,977,600 98 15/16 96 9/16 98 3/16 Dow +117
10/19/98 3,424,500 99 13/16 97 1/16 97 9/16 Analysts reiterate buys
10/20/98 3,921,500 99 95 13/16 96 11/16 VRxs -1%
10/21/98 3,920,700 98 7/16 95 1/2 98
10/22/98 2,490,800 100 3/4 97 5/8 100 3/4
10/23/98 4,549,800 104 1/2 99 11/16 103 13/16 Last <100 day
10/26/98 3,796,000 106 7/8 104 106 1/2 V Rxs -2%
10/27/98 3,278,400 106 7/8 105 7/8 106 5/16
10/28/98 2,459,100 106 3/4 104 5/8 105 11/16
10/29/98 2,600,200 107 3/4 105 3/16 107 5/8
10/30/98 2,742,300 108 1/4 106 5/8 107
11/02/98 3,003,700 108 1/2 106 1/4 108 1/2 V Rxs -3%
11/03/98 2,344,800 109 7/16 107 5/16 109 1/4 Election Day- Dems surprise
11/04/98 4,014,900 110 106 106
11/05/98 2,933,800 107 1/2 105 107 3/8
11/06/98 3,638,600 109 3/4 106 5/8 109 1/2 1998 R&D Meeting
11/09/98 2,728,400 109 11/16 107 108 1/4 V Rxs +2%
11/10/98 3,035,900 109 3/4 106 13/16 108 5/8 ACR Meeting
11/11/98 2,607,400 108 1/2 105 1/2 106 1/16 AHA Meeting
11/12/98 2,126,800 106 1/2 104 104 5/16
11/13/98 1,789,700 105 15/16 104 3/4 105 1/2
11/16/98 2,166,300 108 15/16 106 9/16 108 13/16 V Rxs +5%
11/17/98 3,553,000 111 108 109 1/2
11/18/98 2,749,800 111 5/8 108 9/16 111 3/8
11/19/98 3,245,200 111 3/4 110 1/16 110 9/16
11/20/98 2,412,800 112 110 3/8 112 Dow +104
11/23/98 4,944,800 116 7/8 112 5/16 116 11/16 Dow +215
11/24/98 3,464,100 116 7/8 113 1/2 114
11/25/98 2,520,700 115 3/16 112 5/8 114 3/8 V label revised
11/26/98 Thanksgiving
11/27/98 982,400 115 113 13/16 114
11/30/98 2,183,100 114 11/16 111 5/8 111 15/16 Dow -217
12/01/98 3,179,900 111 15/16 108 5/8 110 15/16
12/02/98 2,743,400 113 1/2 110 7/16 113 1/16 Celebrex FDA panel
12/03/98 2,746,900 114 15/16 110 1/4 110 1/2 Dow -185
12/04/98 2,615,600 113 5/16 110 9/16 112 5/8
12/07/98 2,302,100 115 113 3/4 114 3/8 V refills very strong
12/08/98 2,797,700 116 3/16 114 1/2 116 3/16
12/09/98 3,186,000 117 9/16 115 1/16 116 1/8
12/10/98 2,874,900 117 3/16 113 3/4 114
12/11/98 2,082,800 115 113 1/8 114 7/8 Bob Dole hired for V
12/14/98 2,441,700 113 5/8 111 1/16 111 3/4 Dow -126
12/15/98 2,788,100 115 110 3/16 115
12/16/98 2,495,600 116 1/4 115 1/8 115 3/4 US bombs Iran
12/17/98 2,633,800 117 5/8 115 13/16 116 7/8
12/18/98 3,118,600 116 3/4 115 1/2 116 Clinton impeached
12/21/98 2,834,000 118 1/8 114 1/2 115 1/16 V pending approval in Japan
12/22/98 2,153,100 117 13/16 114 7/8 117 3/16
12/23/98 3,427,500 120 13/16 117 3/4 120 3/8
12/24/98 695,200 120 1/4 118 13/16 119 3/8
12/25/88 Christmas
12/28/98 1,729,300 120 7/16 118 1/2 119 7/16 V Rxs +5.1%
12/29/98 3,813,600 125 5/8 119 1/2 124 3/8 Forbes Company of Year: PFE
12/30/98 2,851,400 126 11/16 123 1/2 126 1/8
12/31/98 2,789,900 128 15/16 125 125 Celebrex Approved
01/04/99 4,407,700 128 15/16 121 13/16 123 3/4
01/05/99 3,592,200 124 5/8 122 1/2 123 7/8
01/06/99 3,148,100 126 13/16 125 1/4 126 5/16
01/07/99 2,750,100 125 3/8 123 7/16 124 1/2
01/08/99 3,779,400 124 5/8 120 1/8 122 1/4
01/11/99 4,895,500 121 9/16 116 3/8 117 11/16 V refills set new high
01/12/99 5,315,700 118 3/8 112 3/4 113 15/16
01/13/99 5,135,700 117 5/8 109 9/16 116 11/16 Peabody Valley/PFE Low
01/14/99 3,118,600 117 1/8 113 113 1/2 Clinton Trial/Brazil
01/15/99 3,165,500 115 3/4 114 1/16 115 11/16
01/18/99 Martin Luther King Day
01/19/99 4,039,500 118 3/8 115 1/8 115 11/16 EPS $0.54 (+$0.02)
01/20/99 3,977,400 120 1/16 116 1/8 119 11/16 Celebrex in pharmacies
01/21/99 3,141,000 121 116 3/8 116 3/8
01/22/99 2,560,000 117 5/8 115 1/16 116 1/8 GPs defy UK V ban
01/25/99 2,694,600 117 15/16 115 5/8 117 5/8 Japan approves V
01/26/99 2,983,000 120 3/8 116 1/2 120 1/4 Positive Celebrex launch
01/27/99 4,624,400 124 121 121 15/16 Hong Kong approves V
01/28/99 4,963,700 127 15/16 121 9/16 127 FDA panel approves Tik.,3-1 split
01/29/99 4,608,800 128 7/8 126 1/4 128 11/16
02/01/99 4,631,300 134 1/4 129 5/8 132 Strong Celebrex Rxs (9.5M)
02/02/99 3,794,400 134 5/8 130 3/8 132 11/16 Peabody Peak
02/03/99 2,897,600 134 7/16 130 3/4 133 1/2
02/04/99 2,655,200 133 3/16 131 131 5/8
02/05/99 2,596,700 131 1/2 129 9/16 130 7/8
02/08/99 2,579,600 132 1/8 129 13/16 131 3/8 Celebrex New Rxs (46M)
02/09/99 2,603,100 130 5/8 125 125 1/8 Peabody Valley
02/10/99 2,891,300 127 15/16 126 126 7/8 WSJ article on Celebrex
02/11/99 2,954,600 132 1/2 128 1/4 132 1/4 PaineWebber: PFE Best Call
02/12/99 3,235,100 133 7/16 128 1/8 130 1/8 Clinton acquitted
02/15/99 Presidents' Day
02/16/99 2,471,500 132 130 3/16 130 13/16 Celebrex New Rxs (91M)
02/17/99 2,212,200 132 7/16 129 5/16 130 Dow -102
02/18/99 2,345,000 132 7/16 125 3/4 131 1/8 Dow +103
02/19/99 2,790,000 129 15/16 127 13/16 128 5/16 ML short-term downgrade
02/22/99 2,677,200 133 13/16 128 5/16 133 Dow +213, Celebrex (121M)
02/23/99 2,550,100 134 7/8 131 7/8 133 7/8
02/24/99 2,166,500 134 7/8 132 3/16 132 1/2
02/25/99 2,514,200 132 5/8 129 3/16 130 7/8
02/26/99 2,269,100 132 1/2 129 7/16 131 15/16
03/01/99 1,734,000 133 1/2 130 133 1/8 Celebrex New Rxs (154M)
03/02/99 2,311,000 134 7/8 132 15/16 133
03/03/99 2,102,100 133 13/16 130 7/8 131 9/16
03/04/99 2,843,800 133 11/16 130 7/8 132 3/4 Dow +191
03/05/99 2,772,900 136 9/16 133 13/16 136 9/16
03/08/99 3,280,900 139 7/8 135 9/16 139 9/16 Celebrex New Rxs (208M)
03/09/99 3,133,900 141 5/8 138 5/8 138 5/8
03/10/99 2,112,200 140 138 15/16 139 3/4 V approved in Canada
03/11/99 2,830,000 140 15/16 139 1/8 140 5/8
03/12/99 2,266,600 140 1/2 138 1/2 140 1/4 V on 20/20
03/15/99 2,388,000 141 5/8 139 7/16 140 11/16 Celebrex New Rxs (230M)
03/16/99 2,181,900 142 3/4 139 7/8 142
03/17/99 1,945,800 142 139 1/4 140 1/4
03/18/99 2,235,700 143 9/16 138 5/16 143
03/19/99 2,492,200 143 1/8 140 3/16 140 7/16 All-time weekly PFE High
03/22/99 1,802,400 143 15/16 140 1/16 143 Celebrex New Rxs (236M)
03/23/99 2,828,200 144 1/2 138 9/16 139 1/4 /Peabody Peak
03/24/99 2,975,400 139 13/16 135 3/4 138 1/8
03/25/99 2,583,300 138 11/16 136 1/2 137 3/4 V sold in Canada
03/26/99 2,408,200 137 3/4 134 7/8 135 Peabody Valley
03/29/99 2,250,700 141 135 7/8 141 Celebrex New Rxs (246M)/Dow 10006
03/30/99 1,975,700 142 3/4 139 7/16 142 1/8
03/31/99 2,294,400 143 7/16 138 5/8 138 5/8 1st Qt PFE +11%
04/01/99 1,873,200 140 1/16 138 139 9/16
04/05/99 2,142,900 142 3/8 138 7/8 142 3/8 Celebrex New Rxs (253M)
04/06/99 2,057,500 141 11/16 139 9/16 140 3/16
04/07/99 2,056,400 139 1/2 139 1/2 139 1/2
04/08/99 2,495,800 142 9/16 139 3/16 142 7/16 Dow 10,198
04/09/99 2,611,600 146 13/16 142 1/8 146 All-time PFE High Weekly Close
04/12/99 2,791,900 150 1/8 145 5/16 150 1/8 Lifetime PFE High
04/13/99 2,542,900 149 7/16 146 1/2 149 5/16
04/14/99 3,148,200 149 5/8 143 144 3/8
04/15/99 10,933,500 130 130 130 PFE 1Qt EPS: $0.62 (+.0.0)
04/16/99 7,701,700 131 3/4 125 15/16 126 15/16 Analysts maintain ratings
04/19/99 8,768,500 128 5/8 115 7/8 118 Peabody Valley/10 Celebrex deaths
04/20/99 7,279,000 122 1/8 116 3/4 118 11/16 Vioxx approved by FDA panel
04/21/99 5,110,100 124 3/8 120 3/8 123
04/22/99 5,300,800 128 5/16 124 1/16 128 5/16 PFE Annual Meeting
04/23/99 3,133,900 130 1/8 126 127 Peabody Peak
04/26/99 3,155,500 128 1/8 123 1/16 123 3/4
04/27/99 4,818,900 124 1/16 120 5/8 121
04/28/99 4,726,300 121 1/16 116 3/4 118 Business Week neg on Big Pharma
04/29/99 6,357,400 119 7/8 114 11/16 115 15/16
04/30/99 6,671,500 117 5/8 114 1/4 115
05/03/99 5,751,700 117 113 5/8 116 7/16 Celebrex New Rxs -11%
05/04/99 4,091,200 118 113 3/4 114 1/4 Positive AUA V studies
05/05/99 4,387,200 118 5/16 113 3/8 118 5/16 Pending Peabody Valley
05/06/99 3,667,900 117 9/16 115 116 3/16
05/07/99 2,868,500 117 3/4 116 116 15/16
|
